Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor-or intermediate-risk cytogenetics
BMC CANCER
Mayer, J; Arthur, C; Delaunay, J; Mazur, G; Thomas, XG; Wierzbowska, A; Ravandi, F; Berrak, E; Jones, M; Li, YH; Kantarjian, HM, 2014: Multivariate and subgroup analyses of a randomized, multinational, phase 3 trial of decitabine vs treatment choice of supportive care or cytarabine in older patients with newly diagnosed acute myeloid leukemia and poor-or intermediate-risk cytogenetics. BMC CANCER 14, doi: 10.1186/1471-2407-14-69
CEITEC authors: